Empowering patients to take action sooner
Cognivue (cognivue.com) earns a Brand Analyzer score of 75 out of 100, placing it in the Brand-Ready tier among Healthcare brands, Technology brands. Among 4611 Healthcare brands analyzed, Cognivue ranks in the 54th percentile (category average 74, leader 96). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 95/100, Digital Presence 100/100, Visual Identity 92/100, Messaging Clarity 95/100, Trust Foundation 83/100, AI Discoverability 73/100, Brand Authority 14/100.
Cognivue is a healthcare technology company that develops FDA-cleared, self-administered digital cognitive assessment devices. Its tools are designed for use by healthcare providers-including physicians, hearing healthcare professionals, and pharmacies-to enable early detection of cognitive impairment across multiple cognitive domains. The company's stated mission is to provide accessible cognitive assessment tools to a broad range of healthcare providers, integrating easily into clinical workflows to support proactive patient care planning.
| Brand Name | Cognivue |
|---|---|
| Domain | cognivue.com |
| Industry | Healthcare, Technology |
| Main Competitors | Linus Health (70/100), BrainCheck (74/100), Cognision, Cogstate (80/100), Neurotrack (80/100), Cambridge Cognition (79/100) |
Moz Domain Authority 36/100 vs category average 38 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Our mission is to provide cognitive assessment tools to a broad range of healthcare providers for the early detection of cognitive impairment." (Meta description: 22 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, + Microdata, og:title, og:description, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost, HubSpot.
Social footprint: verified profiles on YouTube, LinkedIn, X (Twitter), Instagram, GitHub; no detected presence on Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Cognivue scores 21/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Cognivue has a weak AI-visibility profile at 21/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (42/100) and its weakest is visibility (0/100). It benefits from open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 36/100. In a live check, Claude could already identify Cognivue from memory (August 2026) - a sign these signals are paying off.
Live results from asking a general-purpose AI assistant about the brand, checked August 2026.
When asked "What is Cognivue?", Claude could identify the brand as of August 2026. Cognivue makes an FDA-cleared computerized device used by clinicians to quickly screen patients for cognitive impairment, often used in primary care and neurology settings to help detect early signs of conditions like dementia or Alzheimer's disease. Best known for Its handheld computerized cognitive screening device used in clinical settings for early detection of cognitive decline.
When asked "Best brands similar to Cognivue?", Claude would recommend Cognivue as of August 2026. It's a recognized name in objective, standardized cognitive screening tools, so it would come up if someone asked about brands in that specific niche of healthcare technology.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Cognivue's main competitors include Linus Health (70/100), BrainCheck (74/100), Cognision, Cogstate (80/100), Neurotrack. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Brand Analyzer scan
Cognivue and Cogstate are competitors in Healthcare. Brand Analyzer scores Cognivue at 75/100 and Cogstate at 80/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Brand Analyzer scan
Popular alternatives to Cognivue include Linus Health (70/100), BrainCheck (74/100), Cognision, Cogstate (80/100), Neurotrack. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Brand Analyzer scan
Cognivue has low AI-search visibility, scoring 21/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 35, recommendation 42). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Cognivue official site
Cognivue offers FDA-cleared, self-administered digital cognitive assessment devices designed for use in healthcare settings. These tools evaluate multiple cognitive domains to help detect early signs of cognitive impairment. The devices are built to integrate into the workflows of various healthcare providers, including physicians, hearing healthcare professionals, and pharmacies, enabling routine cognitive screening as part of patient care.
Sources: Cognivue official site
Cognivue develops and provides digital cognitive assessment tools that healthcare providers use to screen patients for cognitive impairment. These FDA-cleared devices are self-administered by patients and evaluate multiple cognitive domains, allowing clinicians to identify early signs of cognitive decline. The company's tools are designed to integrate into existing healthcare workflows, supporting physicians, hearing healthcare professionals, and pharmacies in offering cognitive screening as part of patient care.
Sources: Cognivue official site
Cognivue scores 42/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Cognivue official site
Cognivue is a healthcare technology company that produces FDA-cleared digital devices for cognitive assessment. Its products are designed to be self-administered by patients and used by healthcare providers to detect early signs of cognitive impairment. The company focuses on making cognitive testing accessible and easy to incorporate into routine clinical visits across various healthcare settings.
Sources: Cognivue official site
Cognivue can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Cognivue official site
Cognivue's tools are used by healthcare providers such as physicians, hearing healthcare professionals, and pharmacies to screen patients for cognitive impairment. Patients themselves use the self-administered devices during clinical visits. The target audience also includes individuals seeking early detection and management of cognitive decline, making the tools relevant to both clinical staff and the patients they serve.
Sources: Cognivue official site
Cognivue is known for its FDA-cleared, self-administered digital cognitive assessment devices used for early detection of cognitive impairment. The company positions these tools as easy to integrate into busy healthcare workflows, distinguishing them from more time-consuming traditional cognitive testing methods. Its focus on multiple cognitive domains and accessibility for diverse healthcare providers, including hearing professionals and pharmacies, is a notable aspect of its offering.
Sources: Cognivue official site
Ranked closest to Cognivue: Cleveland Clinic Abu Dhabi (75/100), Certinal (75/100), Combat Stress (75/100), Commonwealth Care Alliance (75/100).
A step up - brands to learn from: Zurich Insurance Group (81/100), Zimmer Biomet (81/100).
Category leader: Elsevier (96/100).